Antibiofilm Activity of Eugenol against Aggregatibacter Actinomycetemcomitans ATCC 43718 (serotype B) | ||||
Egyptian Journal of Chemistry | ||||
Volume 66, Issue 4, April 2023, Page 205-208 PDF (303.48 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/ejchem.2022.143899.6278 | ||||
![]() | ||||
Authors | ||||
Diyah Tri Utami ![]() | ||||
1Department of Pharmacy, Universitas Sebelas Maret, Jl. Ir. Sutami 36A, Surakarta, 57126, Indonesia | ||||
2Postdoctoral Program Pusat Riset Bahan Baku Obat dan Obat Tradisional (Research center for Medical Raw Materials and Traditional Medicine), National Research & Innovation Agency, Kawasan Puspiptek, Serpong 15314, Indonesia | ||||
3Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Gadjah Mada, Sekip Utara, Yogyakarta 55281, Indonesia. | ||||
4Pusat Kolaborasi Riset Biofilm (Biofilm Research Collaboration Centre, UGM-BRIN), Jl. Farmako Sekip Utara, Yogyakarta 55281, Indonesia | ||||
5Pusat Riset Bahan Baku Obat dan Obat Tradisional (Research center for Medical Raw Materials and Traditional Medicine), National Research & Innovation Agency, Kawasan Puspiptek, Serpong 15314, Indonesia | ||||
Abstract | ||||
Eugenol is the major constituent [70% to 90%] in the aromatic oil extract from Syzygium aromaticum (cloves) and Cinnamomum zeylanicuma, which is widely used as a flavouring for meats, stews, cakes, and teas. This plays a major role in the microbial activity against oral bacteria, specifically Aggregatibacter actinomycetemcomitans ATCC 43718 (serotype B), which causes periodontitis in humans. Therefore, this study aims to evaluate eugenol for its antibiofilm activity against Aggregatibacter actinomycetemcomitans ATCC 43718 (serotype B). An inhibition growth assay was used with the microdilution method, which often utilized a 96-microplate with an anaerobic technique. Absorbance was also measured by a microplate reader on λ of 595 nm, with the optical density (OD) value used to determine the inhibition percentage. To evaluate biofilm bacterial growth after the treatment, SEM analysis was adopted. The results showed that eugenol had an inhibitory effect on A. actinomycetemcomitans at 0.125 % v/v, according to the MBIC50 value. Eugenol showed significant antibiofilm activity (P < 0.05) against A. Actinomycetemcomitans. This proved that the biofilm bacterial growth was effectively inhibited by the chemical compound. In this case, the extracellular polymeric substance (EPS) matrix degraded after the treatment of the cell biofilm. Based on these results, eugenol was observed to have a great potential in periodontitis, as an inhibitor against the biofilm growth of A. actinomycetemcomitans ATCC 43718 (serotype B). | ||||
Keywords | ||||
Biofilm; Eugenol; Aggregatibacter actinomycetemcomitans ATCC 43718 (serotype B) | ||||
Statistics Article View: 651 PDF Download: 156 |
||||